Total Payments
$21,547
2024 Payments
$3,850
Companies
16
Transactions
23
Medicare Patients
745
Medicare Billing
$98,908
Payment Breakdown by Category
Consulting$21,260 (98.7%)
Food & Beverage$175.71 (0.8%)
Other$100.00 (0.5%)
Education$11.90 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,260 | 10 | 98.7% |
| Food and Beverage | $175.71 | 11 | 0.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100.00 | 1 | 0.5% |
| Education | $11.90 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $7,723 | 5 | $0 (2021) |
| Ultragenyx Pharmaceutical Inc. | $6,050 | 2 | $0 (2023) |
| UCB SA | $3,850 | 3 | $0 (2024) |
| Cyberonics, Inc. | $1,580 | 1 | $0 (2017) |
| Zogenix Inc. | $1,100 | 1 | $0 (2020) |
| BIOCODEX, INC. | $1,000 | 1 | $0 (2020) |
| LivaNova USA, Inc. | $100.00 | 1 | $0 (2020) |
| NEUROPACE, INC. | $28.22 | 1 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $16.22 | 1 | $0 (2019) |
| JAZZ PHARMACEUTICALS INC. | $14.90 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,850 | 3 | UCB SA ($3,850) |
| 2023 | $6,050 | 2 | Ultragenyx Pharmaceutical Inc. ($6,050) |
| 2022 | $27.93 | 2 | ABBVIE INC. ($14.73) |
| 2021 | $59.73 | 4 | Eisai Inc. ($31.00) |
| 2020 | $9,880 | 5 | Eisai Inc. ($7,680) |
| 2019 | $31.12 | 2 | Sunovion Pharmaceuticals Inc. ($16.22) |
| 2018 | $54.50 | 3 | NEUROPACE, INC. ($28.22) |
| 2017 | $1,594 | 2 | Cyberonics, Inc. ($1,580) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/29/2024 | UCB SA | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Neurology | ||||||
| 11/08/2024 | UCB SA | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: Neurology | ||||||
| 01/05/2024 | UCB SA | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Neurology | ||||||
| 08/02/2023 | Ultragenyx Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| 02/15/2023 | Ultragenyx Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $4,400.00 | General |
| 11/06/2022 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Neurology | ||||||
| 04/20/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2021 | HARMONY BIOSCIENCES LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $14.67 | General |
| Category: Neurological Disorders | ||||||
| 09/27/2021 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $14.61 | General |
| Category: Neurology | ||||||
| 07/26/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: PRIMARY CARE | ||||||
| 07/07/2021 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $16.39 | General |
| Category: Neurology | ||||||
| 12/16/2020 | Zogenix Inc. | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Treatment of seizures | ||||||
| 12/06/2020 | Eisai Inc. | Fycompa (Drug) | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
| Category: Neurology | ||||||
| 09/19/2020 | BIOCODEX, INC. | DIACOMIT (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Antiepileptic | ||||||
| 08/03/2020 | Eisai Inc. | Fycompa (Drug) | Consulting Fee | Cash or cash equivalent | $5,520.00 | General |
| Category: Neurology | ||||||
| 06/24/2020 | LivaNova USA, Inc. | VNS Therapy (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: NEUROLOGY | ||||||
| 08/15/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: CNS | ||||||
| 09/27/2018 | Eisai Inc. | Belviq (Drug) | Education | Cash or cash equivalent | $11.90 | General |
| Category: Nutrition and Weight Loss | ||||||
| 07/18/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $14.38 | General |
| 02/01/2018 | NEUROPACE, INC. | RNS System (Device) | Food and Beverage | Cash or cash equivalent | $28.22 | General |
| Category: Epilepsy | ||||||
| 07/07/2017 | Valeant Pharmaceuticals North America LLC | MIGRANAL (Drug), DIASTAT, ZELAPAR | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: NEUROLOGY | ||||||
| 02/23/2017 | Cyberonics, Inc. | VNS Therapy (Device) | Consulting Fee | Cash or cash equivalent | $1,579.86 | General |
| Category: VNS Therapy (Product Class) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 64 | 73 | $42,490 | $7,832 |
| 2022 | 2 | 122 | 148 | $94,660 | $17,491 |
| 2021 | 3 | 276 | 356 | $226,340 | $43,270 |
| 2020 | 5 | 283 | 351 | $196,945 | $30,315 |
Total Patients
745
Total Services
928
Medicare Billing
$98,908
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 61 | $33,550 | $6,017 | 17.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $8,940 | $1,815 | 20.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 57 | 68 | $50,660 | $9,430 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 80 | $44,000 | $8,062 | 18.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 157 | 212 | $115,950 | $20,511 | 17.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 107 | 132 | $98,340 | $20,418 | 20.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $12,050 | $2,340 | 19.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 170 | 232 | $126,625 | $19,492 | 15.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 30 | 32 | $23,840 | $3,444 | 14.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 54 | 58 | $21,400 | $2,843 | 13.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 18 | 18 | $14,800 | $2,789 | 18.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 11 | 11 | $10,280 | $1,747 | 17.0% |
About Dr. Orrin Devinsky, M.D
Dr. Orrin Devinsky, M.D is a Neurology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679581623.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Orrin Devinsky, M.D has received a total of $21,547 in payments from pharmaceutical and medical device companies, with $3,850 received in 2024. These payments were reported across 23 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($21,260).
As a Medicare-enrolled provider, Devinsky has provided services to 745 Medicare beneficiaries, totaling 928 services with total Medicare billing of $98,908. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location New York, NY
- Active Since 08/04/2006
- Last Updated 03/10/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1679581623
Products in Payments
- Fycompa (Drug) $7,711
- Fintepla (Drug) $4,963
- VNS Therapy (Device) $1,680
- DIACOMIT (Drug) $1,000
- RNS System (Device) $28.22
- APTIOM (Drug) $16.22
- XYREM (Drug) $14.90
- BOTOX (Biological) $14.73
- Wakix (Drug) $14.67
- MIGRANAL (Drug) $14.33
- NURTEC ODT (Drug) $14.06
- Belviq (Drug) $11.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in New York
Dr. Stephen Krieger, Md, MD
Neurology — Payments: $1.6M
Neurology $1.6M
Dr. David Dodick, M.d, M.D
Neurology — Payments: $765,174
Neurology $765,174
Dr. David Simpson, M.d, M.D
Neurology — Payments: $638,492
Neurology $638,492
Steven Wolf, Md, MD
Neurology — Payments: $585,108
Neurology $585,108
Dr. Alexander Shtilbans, Md, Ph.d, MD, PH.D
Neurology — Payments: $550,165
Neurology $550,165
Dr. Fred Lublin, M.d, M.D
Neurology — Payments: $549,390
Neurology $549,390